Bladder hydrodistension in treating patients with interstytial cystitis/ bladder pain syndrome

Аль-Шукри, С Х; Kuzmin, Igor V.; Slesarevskaya, M N; Ignashov, Yuriy A

doi:10.18565/urology.2018.1.26-29

Cited by 9 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В данном исследовании представлены результаты изучения клинических симптомов и цистоскопии с гидродистензией у женщин с этим заболеванием. Диагноз ИЦ/СБМП основан на симптоматических и урологических данных, включая характерные цистоскопические признаки после гидродистензии [16,17,18]. С помощью опросников PUF, VAS, USS в совокупности мы оценили проявление симптомов дизурии и боли.…”

Section: Discussionunclassified

“…Противоречивость результатов вызывает дискуссию о полезности цистоскопии с гидродистензией в диагностике ИЦ/СБМП. Отмечается, что при цистоскопии внешний вид стенки мочевого пузыря после гидродистензии не может быть постоянным с течением времени, а отсутствие начальных признаков гломеруляций или терминальной гематурии не исключает дальнейшего развития этих признаков болезни при последующей оценке [6,18].…”

Section: Discussionunclassified

“…К характерным цистоскопическим показателям этого синдрома относятся гломеруляции, петехиальные кровоизлияния и язвы слизистой оболочки мочевого пузыря. Проводимая во время цистоскопии гидродистензия мочевого пузыря увеличивает результативность диагностики ИЦ/ СБМП благодаря повышению частоты выявления язвенных поражений [18].…”

Section: Discussionunclassified

See 2 more Smart Citations

The Value of Cystoscopy in the Assessment of Interstitial Cystitis/Bladder Pain Syndrome

Sholan

2021

Acta biomedica scientifica

View full text Add to dashboard Cite

Background. There are significant differences in the diagnosis of interstitial cystitis/painful bladder syndrome (IC/ BPS), in particular, controversy regarding the diagnostic role of cystoscopy or hydrodistension cystoscopy.The aim of the study was to evaluate the results of cystoscopy with hydrodistension in women with IC/BPS.Materials and methods. The study involved 126 women with IC/BPS, mean age – 46.7 ± 14.0 years. The duration of the disease was 6.0 ± 2.8 years. Questionnaires PUF, VAS, USS, and potassium test were used. Cystoscopy and urinary bladder hydrodistension were performed.Results. The sum of points on the PUF scale was 8.14 ± 1.76, on the VAS scale – 5.45 ± 0.93, on the USS scale – 2.63 ± 0.91. A positive potassium test was detected in 91.3 % of cases, the sensitivity of the test was 86.5 %, the specificity – 84.6 %. The anatomical bladder capacity was 308.0 ± 77.5 ml. The average indicator of maximum bladder filling in women with mild pain was higher than in moderate and severe pain by 30.9 % (p < 0.05) and 53.0 % (p < 0.01), respectively. In 11.9 % of cases, polyps were detected at the external opening of the urethra. During cystoscopy, diffuse mucosal bleeding was detected in 39.8 % of cases, diffuse submucosal bleeding – in 21.4 %, rare glomerulations – in 14.3 %, Gunner’s lesions in 12.7 % of cases. After hydrodistension, the changes were more often diffuse (n = 57). There was a significant relationship (r = –0.57, p < 0.01) between the maximum filling of the bladder and the degree of severity of mucosal abnormalities. The severity of changes in the mucous membrane of the bladder positively correlated with the sum of points on the PUF questionnaire (r = +0.61, p = 0.003), on the VAS questionnaire (r = +0.59, p = 0.008) and according to the USS questionnaire (r = +0.66, p = 0.005).Conclusion. Cystoscopy can be used to examine IC/BPS in accordance with the recommendations of international societies. The obtained data can help to improve the effectiveness of IC/PBS diagnostics.

show abstract

Section: Discussionunclassified

See 1 more Smart Citation

The Value of Cystoscopy in the Assessment of Interstitial Cystitis/Bladder Pain Syndrome

Sholan

2021

Acta biomedica scientifica

View full text Add to dashboard Cite

show abstract

“…Patients for whom conservative and oral medication treatments produce insufficient effects require endoscopic treatment, such as transurethral resection and cauterization (TUR-C) of the Hunner lesions and hydrodistension of the bladder. However, TUR-C leads to symptom recurrence and hydrodistension has a short duration of efficacy [ 2 , 3 ]. Therefore, clinicians and scientists are interested in developing new treatment options.…”

mentioning

confidence: 99%

Commentary on “New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave”

Kim

2020

Int Neurourol J

View full text Add to dashboard Cite

“…В клинических рекомендациях представлены различные схемы лечения заболевания. На первых этапах больным назначают поведенческую и медикаментозную терапию, а при их неэффективности проводится внутрипузырное малоинвазивное, а в редких случаях -и хирургическое лечение [2, 8,11,14].…”

unclassified

Botulinum toxin type A in the treatment of bladder pain syndrome in women: initial results

et al. 2018

View full text Add to dashboard Cite

We present the results of botulinum toxin type A (BT-A) treatment in 49 women (aged 41-65 years) with bladder pain syndrome. Previously, all patients underwent oral and intravesical drug therapy in addition to hydrodistention of the bladder without significant clinical effect. BT-A at a dose of 100 U (20 points at 5 units) was injected into the bladder under general anesthesia. Treatment results were evaluated 3 months after the treatment using specialized questionnaires such as the Pelvic Pain and Urgency/Frequency (PUF) Scale, O’Leary-Sant Symptom Index and Interstitial Cystitis Scale, visual analogue pain scale (VAS), and urinary diaries. Remarkably, the treatment was effective in 46 (93.8%) patients. By the end of the third month after the BT-A injection, the PUF Scale score, the O’Leary-Sant Symptom and Interstitial Cystitis Scale, and VAS reduced by 41.3%, 32%, and 34%, respectively, and urination frequency decreased by 38.5%. Thus, BT-A is an effective method for treating bladder pain syndrome in patients who are refractory to other treatment methods. (For citation: Al-Shukri SH, Kuzmin IV, Slesarevskaya MN, Ignashov YuA. Botulinum toxin type A in the treatment of bladder pain syndrome in women: initial results. Urologicheskie vedomosti. 2018;8(2):5-10. doi: 10.17816/uroved825-10).

show abstract

Bladder hydrodistension in treating patients with interstytial cystitis/ bladder pain syndrome

Cited by 9 publications

References 0 publications

The Value of Cystoscopy in the Assessment of Interstitial Cystitis/Bladder Pain Syndrome

The Value of Cystoscopy in the Assessment of Interstitial Cystitis/Bladder Pain Syndrome

Commentary on “New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave”

Botulinum toxin type A in the treatment of bladder pain syndrome in women: initial results

Contact Info

Product

Resources

About